Hainan Shuangcheng Pharmaceuticals Co.,Ltd. Posted 17.4 Million Yuan Net Loss in First Three Quarters of 2023

Hainan Shuangcheng Pharmaceuticals Co.,Ltd. (海南双成药业股份有限公司) (002693.SZ) reported a net loss of 17.4 million yuan in the first three quarters of 2023, widening 12.9% year-on-year.

Meanwhile, the company posted 182.2 million yuan in revenue, down 7.9% year-on-year.

At the end of the reporting period, it had 861.5 million yuan in total assets and 284.6 million yuan in total liabilities, with a liability-to-asset ratio of 33%.